EUVIMEDEUVIMED entdecken
Open Access

Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein

Ayna Alfadhli, CeAnn Romanaggi, Robin Lid Barklis, Eric Barklis iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01742-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Ayna Alfadhli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Oregon Health & Sciences University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Gene Products, env, HIV-1, env Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

How HIV-1 Env trimers assemble into virus particles remains incompletely understood. In restrictive cells, viral incorporation of Env is dependent on the Env CT and on the MA protein, which assembles lattices composed of hexamers of trimers in immature and mature viruses. Recent evidence indicates that CT assembles trimeric baseplate structures that require membrane-proximal residues to interface with trimeric transmembrane domains and C-terminal helices in the CT. We found that mutations of these membrane-proximal residues impaired replication in restrictive cells. This defect was countered by a MA mutation that does not localize to any obvious interprotein regions but was only inefficiently suppressed by a MA mutation that stabilizes MA trimers and has been shown to suppress other CT-dependent Env defects. Our results suggest that efficient suppression of baseplate mutations involves stabilization of MA inter-trimer contacts and/or direct MA-CT associations. These observations shed new light on how Env assembles into virions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Products, envHIV-1env Gene Products, Human Immunodeficiency VirusAntigens, ViralCell LineMutationProtein DomainsViral Matrix ProteinsVirus Replication

Stichwörter der Autor:innen

HIV-1

Substanzen

Antigens, ViralGene Products, envViral Matrix Proteinsenv Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Oregon Health & Sciences University, Portland, Oregon, USA.

ORCID-Profile: Eric Barklis

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Alfadhli, A., Romanaggi, C., Barklis, R. L., & Barklis, E. (2024). Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein. Journal of Virology. https://doi.org/10.1128/jvi.01742-23

Vancouver

Alfadhli A, Romanaggi C, Barklis RL, Barklis E. Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein. Journal of Virology. 2024. doi:10.1128/jvi.01742-23

BibTeX
@article{Alfadhli2024,
  author = {Alfadhli, Ayna and Romanaggi, CeAnn and Barklis, Robin Lid and Barklis, Eric},
  title = {Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01742-23}
}
Kostenlos starten →